Clinical Trial Update: TULIP ReTrain Study [NA]

View source ↗

Summary

This is a clinical trial update for the TULIP ReTrain study in prostate cancer. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Prostate Cancer | NA | Status: NOT_YET_RECRUITING